Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?

Omega-3 Fish Oils and Atrial Fibrillation: My Story

OBJECTIVE: The objective of this study was to review and evaluate published evidence on the use of omega-3 fatty acid in the prevention and treatment of atrial and ventricular arrhythmias. Postulated mechanisms of the antiarrhythmic effects of omega-3 fatty acid are discussed. DATA SOURCES: Peer-reviewed articles/abstracts published in English language were identified from MEDLINE and Current C...

Ablation of atrial fibrillation: what can we tell our patients?

Although catheter-based radiofrequency ablation is no longer experimental, it is not yet the first-line treatment for most patients. The authors describe how this procedure works, its indications, benefits, and limitations, and important points to communicate to potential candidates for this procedure.

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

Dronedarone is a new antiarrhythmic agent that was recently approved for the prevention of cardiovascular hospitalization driven by atrial fibrillation/flutter. Its approval was based largely on the results of the ATHENA (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death From Any ...

Atrial fibrillation ablation: how far have we come?

Linear ablation for atrial fibrillation: have we come full circle?.

The evolution of effective and broadly applicable strategies for percutaneous ablation of atrial fibrillation (AF) has followed a complex course over the past decade. In 1994, Swartz et al. (1) reported successful percutaneous ablation of AF with multiple long linear lesions. Conceived as a replication of the surgical MAZE, the procedure deployed specifically tailored long sheaths to facilitate...